The confounding effect of covariates in the estimation of the relative risk has been variously approached by many authors.
1
The confounding effect of covariates in the estimation of the relative risk has been variously approached by many authors.
Using a retrospective study design and assuming a disease of low risk, Mantel and Haenszel (1) sub-classified the population by the levels of the covariate and estimated the average relative risk (which would be the relative risk when this parameter is constant over all sub-classifications) by pooling over the sub-classifications. Wynder et al. (2) recommended the use of the sample standardized mortality ratio. Miettinen (3) endeavored to partition the crude relative risk estimator into two components: one component was attached by him to the risk factor, using the recommendation in Wynder et al. (2) ; the other component was attributed by him to the covariate.
This notion of components is examined below and the nature of one of the components is shown to be different from that pointed out by Miettinen (3) .
To do this, we consider populations with disease state D, risk factor A and a covariate X-possibly a risk factor-each of which is binary. Let the levels of D be denoted by D u D 2 , the levels of A by A,, A 2 and the levels of X by X lt X 2 such that subscript 1 denotes presence of the disease, risk factor or covariate, and subscript 2 absence.
PROSPECTIVE STUDIES
Suppose we take random samples from the exposed population, A,, and from the unexposed population, A 2 . Denote the resulting sample cell frequencies by n iik = Then, by a direct probability argument, the crude relative risk, p, can be written in terms of the parameters r u and TT( as:
(1-P = nr + (1 -vjr Relation 2 may be re-cast as:
where p A is the relative risk of the disease associated with A and p x is the relative risk of the disease associated with the covariate X. Let
G = (4)
Then, relation 3 may be re-written as:
Miettinen (3) expressed p as
where p* was said to be the relative risk component attributable to the covariate when only one was assumed to be present. Clearly, p* and G should represent the same thing. This would imply that p* requires redefinition.
To clarify the situation, we shall examine the estimator, p* of p* as given by Miettinen (3) who derived the estimator by simulating the removal of the effect of the risk factor. Such simulation will affect the "uii j -1> 2. Let these frequencies, after simulation, be denoted by n* ui ,j =1,2. Note that
so that Now, the definition of p* as given by Miettinen (3) is: 1 2) ' Relation 14 may be re-cast as:
. 7T,(p x -1) + 1 P* = ^ ( 9) X " 1) + 1 (15) so that p* and G are one and the same. Thus, p* is not a relative risk component attributable to the covariate. Example. We observe from relation 14 that if ITI = TT S , then p* = G = 1 and when this holds and if we use a fairly large sample, we would expect p* to be close to unity as was observed in the data used by Miettinen (3) , given in table 1, which presents the occurrence of drug-attributed rash in relation to allopurinol exposure among recipients of ampicillin. Using these data in relation 13, we find Thus p* is simply a bias factor when the assumption of constant relative risk holds and when TTI 4-TT 2 . When ti x = TTJ, p* is unity so that in such case p is a consistent estimator of p A . When the assumption of constant relative risk does not hold, both components of p require very careful examination for proper interpretation.
RETROSPECTIVE STUDIES
A similar conclusion is reached in the retrospective study context where the crude odds ratio, i//, may be shown to be given by:
1 -m It J where >fi A = odds ratio pertaining to factor A mu = Prob {AJDtK } )
Relation 17 assumes that the odds ratios at both levels of the covariate are equal so that for a low risk disease, the odds ratio \p A closely approximates the relative risk p A , as established by Cornfield (4) . Thus, it is clear that if we write ip as:
as in the prospective study design, \p* is simply a bias factor unless it is equal to unity, in which case the estimator i/» of \p is a consistent estimator of \p A , and hence of p A in the particular case where the disease is of low risk.
Example. An example is provided by Miettinen (3) and the data are shown in table 2, where the disease is venous thrombosis, the risk factor is oral contraceptives and the covariate is age.
Using the likelihood estimates for /n^, andP ( , (i,j = 1, 2) and the equal relative risk estimates at each of the levels of the covariate in the sample correspondent of relation 17, one finds that: i// = 2.62 ip A = 2.25 t/** = 1.16
In this example, ip* does not appear to be very different from unity, and it may well be that its apparent divergence from unity is due to sampling variability.
To obviate the need to test the hypothesis that >p* = 1 in the retrospective study situation, an easier procedure for the estimation of \p A in the presence of covariates is to sub-classify by levels of the covariate(s) before sampling, as is done in Mantel and Haenszel (1). 
REPLY BY DR. MIETTINEN
In the above article, Ayenew and McHugh (1) address "the confounding effect of covariates." This concept is left without express definition, but it is apparent that to these authors "confounding effect" is synonymous with "effect," unspecified. (They seem to consider this effect in terms of "the relative risk of the disease associated with the covariate X", denoting it by Px-) In point of fact, though, a sharp distinction needs to be made between "confounding effect" and mere "effect" of a covariate (2). Confounding is the admixture of the effect under study with that of an extraneous variate (covariate). Thus, when studying the effect of a particular exposure on the risk of a given illness, an extraneous variate has a confounding effect only insofar as it not only has an effect of its own on the risk of the illness but is, in addition, associated with the exposure under study. Therefore, any measure of the confounding effect of a given variate must reflect not only its effect proper but also its association with the exposure whose effect is the object of study. (The "effect" of the extraneous variate is not synonymous with its association with the illness in the data at issue, conditional on the exposure variate, because a chance association is but a pseudoeffect and can form the basis of pseudoconfounding only. Instead, the "effect" can only be reflected by that association which tends to occur in general, due to actual effect or as a result of trends in observation errors. By contrast, the association of the covariate with the exposure is singularly a question of the data at issue.)
The criticism of my proposed measure of confounding, presented by Ayenew and McHugh, reflects, firstly, their failure to distinguish confounding effect from mere effect of the covariate, in the above sense. In addition, their criticism springs from a misinterpretation of my paper. They find that my proposed measure involves not only a measure (p x -1) of the effect of the covariate but also parameters (TT { ) that have to do with the association between the covariate and the exposure. Instead of recognizing that this is what the measure should involve they conclude that my measure requires redefinition. They attempt to clarify the situation and end up asserting
